The minimal informative monitoring interval of N-terminal pro-B-type natriuretic peptide in patients with stable heart failure

被引:0
作者
Zhehao Dai
Taku Asano
Osamu Takahashi
Nobuyuki Komiyama
Sachiko Ohde
机构
[1] Department of Cardiology,Graduate School of Public Health
[2] St. Luke’s International Hospital,undefined
[3] St. Luke’s International University,undefined
来源
BMC Cardiovascular Disorders | / 20卷
关键词
N-terminal pro-B-type natriuretic peptide (NT-proBNP); Heart failure; Minimal informative monitoring interval; Signal-to-noise ratio;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 165 条
[1]  
Bettencourt P(2004)N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients Circulation 110 2168-2174
[2]  
Azevedo A(2004)Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol prospective randomized cumulative survival (COPERNICUS) trial Circulation 110 1780-1786
[3]  
Pimenta J(2015)Prognostic value of NT-proBNP in heart failure with preserved versus reduced EF Heart. 101 1881-1888
[4]  
Frioes F(2017)2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Failure Society of America J Am Coll Cardiol 70 776-803
[5]  
Ferreira S(2019)Heart failure Association of the European Society of cardiology practical guidance on the use of natriuretic peptide concentrations Eur J Heart Fail 21 715-731
[6]  
Ferreira A(2011)Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction J Am Coll Cardiol 58 1881-1889
[7]  
Hartmann F(2015)Improvement in left ventricular ejection fraction and reverse remodeling in elderly heart failure patients on intense NT-proBNP-guided therapy Int J Cardiol 191 286-293
[8]  
Packer M(2018)Does natriuretic peptide monitoring improve outcomes in heart failure patients? A systematic review and meta-analysis Int J Cardiol 263 80-87
[9]  
Coats AJ(2017)Effect of natriuretic peptide-guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: a randomized clinical trial JAMA 318 713-720
[10]  
Fowler MB(2010)Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) study J Am Coll Cardiol 56 2090-2100